ethinyl estradiol has been researched along with dacuronium in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JK; Fan, BC; Fotherby, K; He, ML; Li, LM; Rekers, H; Song, S; Yang, PJ | 1 |
| Fioretti, P; Kirkman, RJ; Pedersen, JH; Roberts, HE | 1 |
| Akerlund, M; Røde, A; Westergaard, J | 1 |
| Basdevant, A; Conard, J; Degrelle, H; Guy-Grand, B; Guyene, TT; Lapousterle, C; Mayer, M; Pelissier, C | 1 |
| Borm, GF; Coenen, CM; Hollanders, JM; Rolland, R; Thomas, CM | 1 |
| Bischof, P; de Ziegler, D; Fraisse, T; Ibecheole, V; Pillet, C; Streuli, I | 1 |
6 trial(s) available for ethinyl estradiol and dacuronium
| Article | Year |
|---|---|
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Topics: Adult; Apolipoproteins; Blood Glucose; Ceruloplasmin; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Pancuronium; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1992 |
Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
Topics: Adult; Contraceptives, Oral, Combined; Denmark; Ethinyl Estradiol; Female; Humans; Italy; Middle Aged; New Zealand; Norpregnenes; Pancuronium; United Kingdom | 1994 |
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Topics: Adolescent; Adult; Body Weight; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pancuronium; Risk Factors | 1993 |
Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
Topics: Apolipoprotein A-I; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Hemostasis; Humans; Pancuronium; Plasminogen; Prospective Studies; Protein C; Protein S; Renin; Sex Hormone-Binding Globulin; Transcortin; Triglycerides | 1993 |
Changes in androgens during treatment with four low-dose contraceptives.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hydroxyprogesterones; Luteal Phase; Norgestrel; Norpregnenes; Pancuronium; Progestins; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1996 |
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids.
Topics: Administration, Intravaginal; Adult; Anti-Mullerian Hormone; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pancuronium | 2008 |
1 other study(ies) available for ethinyl estradiol and dacuronium
| Article | Year |
|---|---|
Mercilon--a new low-dose combined oral contraceptive.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Pancuronium; Progesterone Congeners | 1989 |